Former Elected County Coroner Indicted for Illegal Distribution of Controlled Substances | OPA | Department of Justice

A federal grand jury in the Eastern District of Kentucky returned an indictment today charging a former elected county coroner with illegally distributing controlled substances such as oxycodone and OxyContin.

According to court documents, David W. Suetholz, 73, of Ludlow, Kentucky, a medical doctor who served as the elected county coroner for Kenton County, Kentucky, until June 30, 2021, unlawfully distributed opioids to three patients on 10 separate occasions between approximately September 2018 and February 2020.

A summons was issued and Suetholz has been directed to appear on Oct. 27. If convicted, Suetholz faces a maximum penalty of 20 years in prison for each count. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

Source: Former Elected County Coroner Indicted for Illegal Distribution of Controlled Substances | OPA | Department of Justice

Thoughtful Thursdays, Stayed on Freedom’s Call page 33, and New Tools

Context, Thought, and Learning: ShiraDest Offers Project Do Better

It is crucial that we each help our society to become more fully inclusive for all of us today, and to come and work together, for all of us, right?  

 

I believe that attention to shared histories, as in DC, may provide part of an answer.  I started a note about that, a few years ago, in my book Stayed on Freedom’s Call:

                “In Washington, D.C., The Time Dollar Youth Court (TDYC) provides alternative youth peer sentencing to first-time juvenile offenders in the District of Columbia, providing a constructive means of instilling respect and responsibility for self and others. The recidivism rate for Youth Court participants is 9% for those who successfully completed the Youth Court Diversion Program (as opposed to 30% for those in the D.C. area who were not referred to Youth Court). ”

In forming the RJI, Dr. Cahn again inspired cooperation, building…

View original post 318 more words

Running the marathon with slippers on!

chapter18

Life’s important learnings often happen at strange places and it was in a Chinese restaurant that I picked up one myself. Waiting for the meal that evening, I watched with unabashed amusement the antics of two toddlers on the opposite table, each trying to negotiate a bowl of soggy vegetable soup. The first kid, sitting on the lap of her mother, dipped a lean lemonade straw inside the bowl and tried desperately to sip in the thick solution. Repeated sucking of the straw placing it at varied angles only resulted in a flattened and collapsing pipe without a drop seeping into the mouth. And quickly learning from the unsuccessful attempt of his sibling, the second one thought differently and took a steel fork that’s placed on the table. He made valiant efforts to scoop out the soup with the fork only to find it leak out completely and the child…

View original post 569 more words

Climate Change and the Melting Glaciers

FunWritings

The effects of climate change is not something we will see in the future, we are seeing it now

Climate solutions that we were told about should be used somehow

We should not be thinking that the environmentalists will do all the work one day

They are not the only ones who will not be living in a great way

When Glaciers melt, sea level rises and islands disappear

It is time for more of us to pay attention to environmental care

We can reduce greenhouse gas emissions and plastic use

We can make a difference when we recycle, reduce and reuse

Photo by Ricardo Esquivel on Pexels.com

We can benefit a lot from protecting earth and working towards living in a sustainable way

We don’t need to keep on moving along the same destructive path every day

There is a lot we can do to fix the damage that…

View original post 103 more words

F.D.A. Panel Meets on Moderna Boosters – The New York Times

A key advisory committee to the Food and Drug Administration voted unanimously on Thursday to recommend a booster shot of the Moderna coronavirus vaccine for many of the vaccine’s recipients, at least six months after a second dose.

The panel endorsed a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs, the same groups of people who became eligible for a Pfizer-BioNTech booster last month. While regulators are not obligated to follow the panel’s recommendations, they typically do.

Although committee members decried the lack of more robust data justifying a booster shot, several emphasized that F.D.A. had already set a precedent by authorizing additional shots on an emergency basis for many recipients of the Pfizer-BioNTech vaccine.

“From a pragmatic point of view,” said Dr. Stanley Perlman of the University of Iowa, “because we’ve already approved it for Pfizer, I don’t see how we can possibly not approve it for Moderna.”

The panel voted after hearing from Moderna officials, agency scientists and a top public health official from Israel, which began offering boosters to Pfizer recipients two and a half months ago.

Dr. Eric Rubin, an adjunct professor of immunology and infectious diseases at the Harvard T. H. Chan School of Public Health, questioned whether Moderna has enough data showing whether a booster shot will create adverse side effects.

Like Pfizer, “Moderna is presenting the results of a relatively small trial,” he said. But “Pfizer had all those real-world data from Israel” on its booster campaign, showing results from “millions of people who received the vaccine,” he said.

Johnson & Johnson has asked the Food and Drug Administration to issue emergency use authorization for a booster for recipients of their vaccines, and the panel will vote Friday on the company’s request. They will also hear then about the initial results of an ongoing federal study that found Johnson & Johnson recipients may benefit more from a booster of Moderna’s or Pfizer’s vaccineLater Thursday, the committee will discuss, but not vote on, whether to consider broader eligibility for boosters of both Pfizer and Moderna’s vaccines, allowing people younger than 65 but not at especially high risk to get them.